Clinical trial
Selection of a Protective T Cell-based HIV-1/FIV Vaccine Devoid of Viral Enhancing Epitopes
NCT02389595 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Selection of a Protective T Cell-based HIV-1/FIV Vaccine Devoid of Viral Enhancing Epitopes
- Lead sponsor
- University of Florida
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- May 31, 2015
- Completion date
- May 31, 2028
- Enrollment
- 270 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
hiv